A meta-analysis with a total of 27 studies which included 3891 gastric cancer patients showed that higher heparanase expression in gastric cancer is associated with clinicopathologic features of depth of invasion, lymph node metastasis, and TNM stage [74]. The gene discussed is HPSE; the disease is gastric cancer.